<p>Patients of Myelodysplastic Syndrome with Mild/Moderate Myelofibrosis and a Monosomal Karyotype are Independently Associated with an Adverse Prognosis: Long-Term Follow-Up Data</p>-Reference-Cited by-同舟云学术

Patients of Myelodysplastic Syndrome with Mild/Moderate Myelofibrosis and a Monosomal Karyotype are Independently Associated with an Adverse Prognosis: Long-Term Follow-Up Data

Published:2020-07 Issue: Volume:Volume 12 Page:5881-5891
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Wang Na^ORCID,Xu Hongzhi,Li Qing,Fang Xiaosheng^ORCID,Liu Jie^ORCID,Sui Xiaohui^ORCID,Zhang Lingyan,Jiang Yujie,Wang Xin^ORCID

Publisher

Informa UK Limited

Subject

Oncology

Reference29 articles.

1. Bone marrow fibrosis in patients with primary myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systems

2. Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes

3. Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico-pathological entity

4. Myelodysplastic syndromes with bone marrow fibrosis: a myelodysplastic disorder with proliferative features

5. Clinical Relevance of Bone Marrow Fibrosis and CD34-Positive Cell Clusters in Primary Myelodysplastic Syndromes

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms;Blood Cancer Journal;2024-04-09

2. Simultaneous blastic plasmacytoid dendritic cell neoplasm and myelofibrosis: A case report;Oncology Letters;2024-03-22

3. Impact of myelofibrosis on patients with myelodysplastic syndromes following allogeneic hematopoietic stem cell transplantation;Journal of Translational Medicine;2024-03-13

4. Comparison of the 2022 World Health Organization Classification and International Consensus Classification in Myelodysplastic Syndromes/Neoplasms;2024-01-03

5. Myelodysplastic Syndromes with Bone Marrow Fibrosis: An Update;Annals of Laboratory Medicine;2022-05-01